Tag - Fc

Pricesmart Inc. (Nasdaq:PSMT), Franklin Covey Co. (Nasdaq:FC) and Cornerstone Therapeutics Inc. (Nasdaq:CRTX) are among the biggest percentage losers in Friday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Investors Title Co. (Nasdaq:ITIC), Rubicon Technology Inc. (Nasdaq:RBCN), M I Homes Inc. (Nasdaq:MHO), MAP Pharmaceuticals Inc. (Nasdaq:MAPP), Trina Solar Ltd. (Nasdaq:TSL) and EZchip Semiconductor Ltd. (Nasdaq:EZCH).

The following small-cap companies are among the newsmakers in after-hours trading Wednesday:

Shares of Dyax Corp. (Nasdaq: DYAX) skyrocketed by $1.70, or 42.5%, to $5.68 in after-hours trading today after the biopharmaceutical company announced positive late-stage trial results for DX-88, its treatment of hereditary angioedema (HAE), an inflammatory condition. Cambridge, Mass.-based Dyax says the findings should position the company to apply for regulatory approval. The drug currently has Fast Track Designation with the U.S. Food and Drug Administration. The latest results showed no drug-related serious adverse side effects and statistically significant improvement of symptoms in patients. Dyax was trading higher on unusually heavy volume of nearly 600,000 shares - more than twice its three-month average volume of 242,000.

SurModics Inc.’s (Nasdaq: SRDX) shares were up $0.07, or 0.2%, to $37.20 in after-hours trading on the news that the company had inked an expanded technology corporate agreement with St. Jude Medical Inc. (NYSE: STJ). Nearly 400,000 shares had changed hands by 5 p.m. ET – more than double the three-month average volume of 159,921 shares. Eden Prarie, Minn.-based SurModics and St. Jude’s plan to work together to commercialize new products being developed in St. Jude’s cardiovascular and cardiac rhythm management divisions.